2020Ynewophiomicsadm, Author at Ophiomics

Menu

The Time for Precision Liver Medicine is Now Precision Liver Medicine is transforming how we tackle the growing burden of

Introducing LiverSphere: A Smarter Way to Work with Liver Research Data Over the past few years, SpecimensDB has been our

Ophiomics was delighted to host the LEOPARD Project’s First Annual Meeting in Lisbon last week! We’re proud to share a

We are incredibly proud of our researcher Maria Gonçalves Reis, who has been selected to give an oral presentation at

We truly enjoyed our time at the EASL Liver Cancer Summit Paris 2025! Over two and a half days, we

We are thrilled to announce that an important clinical validation of our Hepatocellular carcinoma (HCC) prognostic tool, HepatoPredict, has been

Ophiomics will be present @ Medlab Middle East to support our efforts of entering new markets. Contact us if you

As we kick off 2025, we’re proud to reflect on some major milestones that have shaped our journey in 2024:

Ophiomics was present in BioJapan 2024 in Yokohama. It was great to meet old and new friends and to discuss

Ophiomics is a VC-backed ISO 13485 and ISO 9001 certified, clinical-stage Medtech start up developing cutting-edge diagnostic products and services

Ophiomics is present @EASL2024 in Milan. Visit us at Biotech Village BT3 to discover how HepatoPredict will

Navigation:

Search